Thulium Laser and Growth Factors for Androgenetic Alopecia
Recruiting
N/A
Interventional Study
Androgenetic Alopecia (AGA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Androgenetic alopecia (AGA) is a common cause of hair loss worldwide. It mainly affects the frontal and parietal regions of the scalp in up to 70 % of men and 40 % of women and has a significant negative psychological and emotional impact on those affected.
Various therapies are currently approved for the treatment of AGA in men and women, including topical minoxidil, topical or systemic finaster…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women aged 18 and over
* Good general health, no relevant previous illnesses
* Presence of an AGA
* Cognitive ability and willingness to give consent (informed consent)
* Be willing and able to attend follow-up visits
Exclusion Criteria:
* Age \< 18 years
* Pregnant …
Contacts